Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s DiseaseYun‐Cheng Wu, Tianhong Pan|Neurosignals|2011Cited by 478
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Yuying Zhou et al.|Alzheimer s Research & Therapy|2021Cited by 200
The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic ConsiderationsLi Xuan, Yun‐Cheng Wu|Aging and Disease|2020Cited by 128
Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cellsKan Fang, Yun‐Cheng Wu|International Journal of Oncology|2016Cited by 67